Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794465
Max Phase: Preclinical
Molecular Formula: C24H23ClN6O
Molecular Weight: 446.94
Molecule Type: Unknown
Associated Items:
ID: ALA4794465
Max Phase: Preclinical
Molecular Formula: C24H23ClN6O
Molecular Weight: 446.94
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CNc1nc(Nc2ccc(-n3cnc(Cl)c3)c(OC)c2)nc2c1CC[C@H]2c1ccccc1
Standard InChI: InChI=1S/C24H23ClN6O/c1-26-23-18-10-9-17(15-6-4-3-5-7-15)22(18)29-24(30-23)28-16-8-11-19(20(12-16)32-2)31-13-21(25)27-14-31/h3-8,11-14,17H,9-10H2,1-2H3,(H2,26,28,29,30)/t17-/m0/s1
Standard InChI Key: KXPNLMZWAKJGRB-KRWDZBQOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 446.94 | Molecular Weight (Monoisotopic): 446.1622 | AlogP: 5.19 | #Rotatable Bonds: 6 |
Polar Surface Area: 76.89 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 5.11 | CX LogP: 5.22 | CX LogD: 5.22 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: -0.80 |
1. Boy KM,Guernon JM,Zuev DS,Xu L,Zhang Y,Shi J,Marcin LR,Higgins MA,Wu YJ,Krishnananthan S,Li J,Trehan A,Smith D,Toyn JH,Meredith JE,Burton CR,Kimura SR,Zvyaga T,Zhuo X,Lentz KA,Grace JE,Denton R,Morrison JS,Mathur A,Albright CF,Ahlijanian MK,Olson RE,Thompson LA,Macor JE. (2019) Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481., 10 (3): [PMID:30891132] [10.1021/acsmedchemlett.8b00541] |
Source(1):